Exact Mass: 508.2131
Exact Mass Matches: 508.2131
Found 175 metabolites which its exact mass value is equals to given mass value 508.2131
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
6-O-Oleuropeoylsucrose
6-O-Oleuropeoylsucrose is a constituent of the root bark of the olive (Olea europaea). Constituent of the root bark of the olive (Olea europaea)
Belnacasan
Mortonin C
Mortonin D
(2R)-2-[(S)-3-hydroxy-3-methylglutaryloxy]putrescine dicinnamamide|pholiotic acid
Asp Phe Val Glu
Val Glu Phe Asp
Indacaterol Maleate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Indacaterol maleate (QAB149) is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol maleate inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol maleate can also be used in cardiovascular disease research[1][2].
Cys His His Ile
Cys His His Leu
Cys His Ile His
Cys His Leu His
Cys Ile His His
Cys Lys Met Gln
Cys Lys Gln Met
Cys Leu His His
Cys Met Lys Gln
Cys Met Gln Lys
Cys Gln Lys Met
Cys Gln Met Lys
Asp Asp Phe Ile
Asp Asp Phe Leu
Asp Asp Ile Phe
Asp Asp Leu Phe
Asp Glu Phe Val
Asp Glu Val Phe
Asp Phe Asp Ile
Asp Phe Asp Leu
Asp Phe Glu Val
Asp Phe Ile Asp
Asp Phe Leu Asp
Asp Ile Asp Phe
Asp Ile Phe Asp
Asp Leu Asp Phe
Asp Leu Phe Asp
Asp Val Glu Phe
Asp Val Phe Glu
Glu Asp Phe Val
Glu Asp Val Phe
Glu Phe Asp Val
Glu Phe Val Asp
Glu Pro Thr Tyr
Glu Pro Tyr Thr
Glu Thr Pro Tyr
Glu Thr Tyr Pro
Glu Val Asp Phe
Glu Val Phe Asp
Glu Tyr Pro Thr
Glu Tyr Thr Pro
Phe Asp Asp Ile
Phe Asp Asp Leu
Phe Asp Glu Val
Phe Asp Ile Asp
Phe Asp Leu Asp
Phe Asp Val Glu
Phe Glu Asp Val
Phe Glu Val Asp
Phe Ile Asp Asp
Phe Leu Asp Asp
Phe Val Asp Glu
Phe Val Glu Asp
His Cys His Ile
His Cys His Leu
His Cys Ile His
His Cys Leu His
His His Cys Ile
His His Cys Leu
His His Ile Cys
His His Leu Cys
His Ile Cys His
His Ile His Cys
His Leu Cys His
His Leu His Cys
Ile Cys His His
Ile Asp Asp Phe
Ile Asp Phe Asp
Ile Phe Asp Asp
Ile His Cys His
Ile His His Cys
Lys Cys Met Gln
Lys Cys Gln Met
Lys Met Cys Gln
Lys Met Gln Cys
Lys Gln Cys Met
Lys Gln Met Cys
Leu Cys His His
Leu Asp Asp Phe
Leu Asp Phe Asp
Leu Phe Asp Asp
Leu His Cys His
Leu His His Cys
Met Cys Lys Gln
Met Cys Gln Lys
Met Lys Cys Gln
Met Lys Gln Cys
Met Gln Cys Lys
Met Gln Lys Cys
Pro Glu Thr Tyr
Pro Glu Tyr Thr
Pro Thr Glu Tyr
Pro Thr Tyr Glu
Pro Tyr Glu Thr
Pro Tyr Thr Glu
Gln Cys Lys Met
Gln Cys Met Lys
Gln Lys Cys Met
Gln Lys Met Cys
Gln Met Cys Lys
Gln Met Lys Cys
Thr Glu Pro Tyr
Thr Glu Tyr Pro
Thr Pro Glu Tyr
Thr Pro Tyr Glu
Thr Tyr Glu Pro
Thr Tyr Pro Glu
Val Asp Glu Phe
Val Asp Phe Glu
Val Glu Asp Phe
Val Phe Asp Glu
Val Phe Glu Asp
Tyr Glu Pro Thr
Tyr Glu Thr Pro
Tyr Pro Glu Thr
Tyr Pro Thr Glu
Tyr Thr Glu Pro
Tyr Thr Pro Glu
1,1,3,3,3,3-hexamethylindotricarbocyanine perchlorate
VX-765
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C38461 - Caspase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Lonaprisan
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methylvalyl-N-(2-ethoxytetrahydro-5-oxo-3-furanyl)-
2-[[6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-2-quinazolinyl]thio]-N-(2-oxolanylmethyl)acetamide
N-[4-[[2-methoxy-5-[4-oxo-3-(pyridin-4-ylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]acetamide
N-[5-(diethylsulfamoyl)-2-(4-morpholinyl)phenyl]-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[4-[[2-(diethylamino)ethylamino]-oxomethyl]phenyl]-3-[(4-methylphenyl)sulfamoyl]benzamide
BI-1622
BI-1622 is an orally active, potent and highly selective HER2 (ERBB2) inhibitor, with an IC50 of 7 nM. BI-1622 shows greater than 25-fold selectivity over EGFR. BI-1622 shows high antitumor efficacy in vivo in xenograft mouse tumor models with engineered H2170 and PC9 cells and had a favorable agent metabolism and pharmacokinetics profile[1].